Siemens Healthineers Weighs Sale, Carve-Out of Diagnostics Unit, Bloomberg Reports
--Siemens Healthineers is considering strategic options for its diagnostics business, which could be valued at up to $8 billion, with a sale or carve-out among the scenarios being considered, Bloomberg reports, citing unnamed sources.
--The review, which seeks to streamline the German healthcare group's operations, is at an early stage and the company could still opt to keep the assets, but the business would likely attract interest from private-equity groups, according to Bloomberg.
--Siemens Healthineers didn't respond to a request for comment when contacted by Dow Jones Newswires.
Full story: https://shorturl.at/fkpsA
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
November 03, 2023 03:41 ET (07:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks